Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jiangmen Kanhoo Industry Co., Ltd (300340.SZ)
Jiangmen, CN
Established in 1994 and headquartered in Jiangmen, China, Jiangmen Kanhoo Industry Co., Ltd specializes in the production and distribution of rare earth luminescent compounds, primarily serving the Chinese market. The company's extensive product offerings also include cathode substances and automated machinery for lithium-ion battery manufacturing, in addition to LED luminescent materials, catalytic agents, and agricultural light-conversion products. Furthermore, it supplies various other essential components within the upstream lithium-ion battery supply chain.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.32% | -8.81% | -13.94% | -23.27% | -30.47% | -21.83% | -1.93% | -23.45% | -36.39% | -58.25% | -52.61% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 5 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-2.4% Q1'26: -11.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-12.9% Q1'26: -1,026.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-6.7% Q1'26: +11.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-8.1% Q1'26: -7.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-37.4% Q1'26: -19.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.7% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-6.10× Q1'26: -6.18× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
|---|---|---|---|---|---|---|---|
| Revenue |
786.99M
est: 765.00M (+2.9%)
|
2.06B
est: 2.19B (-5.9%)
|
2.20B
est: 2.20B (+0.0%)
|
1.84B
est: 1.84B (-0.1%)
|
1.65B
est: 2.18B (-24.6%)
|
2.59B
est.
|
3.33B
est: 3.09B (+7.9%)
|
| EBITDA |
56.80M
est: -83.31M (+168.2%)
|
187.18M
est: -238.45M (+178.5%)
|
165.22M
est: -239.79M (+168.9%)
|
133.62M
est: -200.60M (+166.6%)
|
-688.81M
est: -237.70M (-189.8%)
|
-282.51M
est.
|
128.28M
est: -336.28M (+138.1%)
|
| EBIT |
38.12M
est: -105.62M (+136.1%)
|
155.58M
est: -302.31M (+151.5%)
|
122.67M
est: -304.01M (+140.4%)
|
83.75M
est: -254.32M (+132.9%)
|
-741.85M
est: -301.36M (-146.2%)
|
-358.16M
est.
|
70.95M
est: -426.33M (+116.6%)
|
| Net Income |
33.59M
est: 45.63M (-26.4%)
|
118.80M
est: 265.38M (-55.2%)
|
53.31M
est: 71.17M (-25.1%)
|
30.43M
est: 49.27M (-38.2%)
|
-744.96M
est: 106.76M (-797.8%)
|
142.35M
est.
|
13.98M
est: 213.52M (-93.5%)
|
| SGA |
76.60M
est: 20.74M (+269.4%)
|
141.33M
est: 59.36M (+138.1%)
|
107.96M
est: 59.69M (+80.9%)
|
123.29M
est: 49.93M (+146.9%)
|
138.22M
est: 59.17M (+133.6%)
|
70.32M
est.
|
141.30M
est: 83.71M (+68.8%)
|
| EPS |
0.18
est: 0.17 (+8.0%)
|
0.56
est: 0.97 (-42.2%)
|
0.25
est: 0.26 (-3.8%)
|
0.14
est: 0.18 (-22.2%)
|
-3.51
est: 0.39 (-1,000.0%)
|
0.52
est.
|
0.07
est: 0.78 (-91.6%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dehui Wu | Secretary, Vice President & Director | — | male |
| Fanyu Zeng | President & Director | — | male |
| Haibin Liu | Executive Vice President, Chief Financial Officer & Director | — | male |
| Jiang Fan | Vice President | — | male |
| Liqin Ma | Accounting Supervisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300340.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
